Skip to main content
Premium Trial:

Request an Annual Quote

Wyeth Extends Affymetrix Supply Deal for Three More Years

NEW YORK (GenomeWeb News) – Wyeth has extended an ongoing microarray supply agreement with Affymetrix for three more years, Affymetrix said today.
 
Under the terms of the agreement, originally signed in 1994, Wyeth will continue to use Affy’s GeneChip technology to identify new drug targets and to study genetic markers linked to therapeutic response.
 
Affy said Wyeth also uses its GeneChip products for disease classification and in predicting clinical progression.
 
No financial terms of the deal were released.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.